CD274 and neoplasm: From a biomarker perspective, very limited data is currently available, although exploratory biomarker analysis from a recently reported trial [122] showed no clinically meaningful associations between objective response and any of the biomarkers, established as predictive in other tumor types, including PD-L1 expression, TMB or MHC-I expression.